Bioconvergence LLC D/B/A Singota Solutions v. Singh

CourtDistrict Court, District of Columbia
DecidedAugust 22, 2022
DocketCivil Action No. 2021-2090
StatusPublished

This text of Bioconvergence LLC D/B/A Singota Solutions v. Singh (Bioconvergence LLC D/B/A Singota Solutions v. Singh) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bioconvergence LLC D/B/A Singota Solutions v. Singh, (D.D.C. 2022).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

BIOCONVERGENCE LLC d/b/a SINGOTA SOLUTIONS,

Plaintiff,

v. Case No. 21-cv-2090 (CRC)

SIMRANJIT JOHNY SINGH,

Defendant.

MEMORANDUM OPINION

Plaintiff Bioconvergence LLC d/b/a Singota Solutions (“Singota”) is a life sciences

company based in Indiana. For the past three and a half years, Singota has been embroiled in

litigation with one of its former employees, Jaspreet Attariwala. Singota claims that Attariwala

stole client contacts and other trade secrets in anticipation of taking a job with one of its

competitors, violating her employment contract and various trade secrets laws. Singota has now

filed suit in this Court against Attariwala’s husband, defendant Simranjit Singh, who resides in

the District of Columbia. 1 It alleges that Singh participated in Attariwala’s efforts to steal

confidential trade secrets and helped conceal this wrongdoing. Proceeding pro se, Singh moves

to dismiss the complaint. For the reasons below, the Court will deny the motion.

I. Background

The Court draws the following facts from the allegations in Singota’s complaint, which it

must accept as true for the purposes of the motion to dismiss. See Sparrow v. United Air Lines,

Inc., 216 F.3d 1111, 1113 (D.C. Cir. 2000).

1 The complaint refers to the defendant as “Mr. Attariwala.” The Court will use the name the defendant chooses in his own briefing—Mr. Singh. A. Attariwala’s Employment with Singota

Singota is an Indiana-based life sciences company. Compl. ¶¶ 12–13. It provides

services to clients in the pharmaceutical, biotechnology, animal health, and medical device

industries, helping them meet FDA standards for sterile products administered by injection. Id.

¶ 13. From September 2015 to December 2018, Attariwala worked as a business development

manager for Singota. Id. ¶¶ 27, 115. In that capacity, she had access to confidential information

about Singota’s business, including current and prospective client lists and proprietary

information about the company’s products and pricing. Id. ¶¶ 37–38. Attariwala’s employment

contract and the company’s handbook required her to keep this information confidential both

during and after her employment, and her contract included a non-compete clause lasting for

twelve months after her departure. Id. ¶¶ 31–35.

In October 2018, while still employed with Singota, Attariwala began interviewing for a

job with Emergent, a Maryland-based biopharmaceutical company that Singota considers a

competitor. Id. ¶¶ 5, 56–57, 63–68. Singota alleges that, both before and after she secured that

new position, Attariwala stole lists of clients and information about their business needs that

Singota had developed, as well as proprietary information about Singota’s business development

and client solicitation strategies. Id. ¶¶ 82–144. Singota claims that at least some of the

information was taken with Mr. Singh’s cooperation and help—with crucial information

forwarded to his personal email, downloaded to his computer, or uploaded to his cloud account.

Id. ¶¶ 50–54.

B. Singota’s Suit Against Attariwala

In January 2019, Singota sent Attariwala a cease and desist letter, demanding that she

comply with the non-compete in her employment agreement and stop using any confidential

2 information she had accessed in violation of that agreement. Id. ¶ 146. Singota also demanded

that Emergent, Attariwala’s new employer, ensure that she complied with the agreement. Id. ¶

149. Singota alleges that, despite assurances from both Attariwala and Emergent, Attariwala

soon used Singota’s proprietary client information in her new role. Id. ¶¶ 147, 152–60.

In late February 2019, Singota sued Attariwala in an Indiana state court. Id. ¶ 167. That

court entered a temporary restraining order and then a preliminary injunction against Attariwala.

Id. ¶¶ 171, 184. Those orders, among other things, precluded Attariwala from using Singota’s

data and required her to preserve, identify, and return any confidential information in her

possession. Id. ¶¶ 171–72, 184. The court appointed a forensic expert, at Attariwala’s expense,

to help identify confidential information still in Attariwala’s possession. Id. ¶¶ 184–86. Singota

alleges that Attariwala delayed providing or concealed devices and accounts with relevant

information from the court-appointed expert—including ones belonging to Mr. Singh. Id.

¶¶ 192, 204. For her refusal to cooperate with the investigation and failure to pay the expert as

ordered, the Indiana state court orally held Attariwala in contempt in April 2019. Id. ¶¶ 207–20.

Soon thereafter, Singota moved to amend its complaint to add Singh as a defendant. See

Mot. Leave to Amend at 1–2, Bioconvergence LLC v. Attariwala, No. 53C01-1902-PL-480

(Monroe Cir. Ct. Apr. 17, 2019). On April 30, 2019, Singota asked to withdraw its amendment

request, without prejudice to refiling should it want to pursue claims against Singh later. See

Mot. Withdraw Mot. Leave to Amend at 1, Bioconvergence LLC v. Attariwala, No. 53C01-

1902-PL-480 (Monroe Cir. Ct. Apr. 30, 2019). The Monroe Circuit Court granted the

withdrawal motion. See Order, Bioconvergence LLC v. Attariwala, No. 53C01-1902-PL-480

(Monroe Cir. Ct. May 9, 2019). Around that same time, Attariwala removed the case against her

to federal court. Compl. ¶ 221.

3 Singota’s case against Attariwala remains ongoing. In December 2019, Southern District

of Indiana Judge Sarah Evans Barker granted Singota’s request for further preliminary injunctive

relief against Attariwala, finding that she had led it “on a months-long wild goose chase in search

of its stolen trade secrets.” Id. ¶ 290–91. Although proceedings in that case were stayed for

several months after Attariwala filed for bankruptcy, id. ¶¶ 293–95, discovery in Singota’s case

against Attariwala now continues, see Order Granting Pl.’s Unopposed Mot. Amend Case Mgmt.

Plan, Bioconvergence LLC v. Attariwala, No. 19-cv-1745 (S.D. Ind. May 27, 2022), ECF No.

382. The parties are set to file dispositive motions in September 2022 and be ready for trial by

July 2023. Id.

C. Singota’s Litigation Against Singh in the Southern District of Indiana

In June 2019, Singota amended its complaint in the Southern District of Indiana case

against Attariwala, again seeking to add Mr. Singh as a defendant. Compl. ¶ 303. The amended

complaint alleged that Singh had received Singota’s confidential information and conspired with

Attariwala to misappropriate trade secrets and help her violate her employment agreement. See

First Am. Compl. ¶¶ 142–62, Bioconvergence LLC v. Attariwala, No. 19-cv-1745 (S.D. Ind.

June 18, 2019), ECF No. 30.

In March 2020, the Southern District of Indiana granted Singh’s motion to dismiss for

lack of personal jurisdiction. See Order Granting Defendant’s Mot. Dismiss (“SDIN

Jurisdictional Order”), Bioconvergence LLC v. Attariwala, No. 19-cv-1745 (S.D. Ind. Mar. 23,

2020), ECF No. 175. It held that Singota had not established that Singh, a District of Columbia

resident, had purposefully directed any of his allegedly tortious conduct at Indiana, sufficient for

that court to exercise personal jurisdiction over him. Id. at 20. The court emphasized, however,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lawlor v. National Screen Service Corp.
349 U.S. 322 (Supreme Court, 1955)
United Mine Workers of America v. Gibbs
383 U.S. 715 (Supreme Court, 1966)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Sparrow, Victor H. v. United Airlines Inc
216 F.3d 1111 (D.C. Circuit, 2000)
American Nat. Ins. Co. v. FDIC
642 F.3d 1137 (D.C. Circuit, 2011)
Victor Herbert v. National Academy of Sciences
974 F.2d 192 (D.C. Circuit, 1992)
Donald Gene Henthorn v. Department of Navy
29 F.3d 682 (D.C. Circuit, 1994)
Citadel Investment Group, L.L.C. v. Citadel Capital Co.
699 F. Supp. 2d 303 (District of Columbia, 2010)
Richards v. Duke University
480 F. Supp. 2d 222 (District of Columbia, 2007)
OPPORTUNITY KNOCKS, INC. v. Maxwell
618 F. Supp. 2d 920 (N.D. Indiana, 2009)
Direct Supply, Inc. v. Specialty Hospitals of America, LLC
878 F. Supp. 2d 13 (District of Columbia, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Bioconvergence LLC D/B/A Singota Solutions v. Singh, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bioconvergence-llc-dba-singota-solutions-v-singh-dcd-2022.